Indian manufacturers during the past few quarters. Though with normalizing inventories the API prices may normalize in the near term, nevertheless Indian manufacturers remain in a sweet spot and will continue getting opportunities to drive their growth over the long term too.Global manufacturers aiming to de-risk their supplies from China will continue exploring India's supply options.
This will continue offering opportunities to Indian manufacturers. The Indian pharma manufacturers already supplying ingredients and generic formulations to various developed markets already have manufacturing facilities compliant to the US or European manufacturing norms.Also Read | Inside the rumble in India’s coding junglePost the onset of the pandemic as.